Two Adjacent Phenylalanines In the NMDA Receptor GluN2A Subunit M3 Domain Interactively Regulate Alcohol Sensitivity and Ion Channel Gating by Ren, Hong et al.
Marquette University
e-Publications@Marquette
Biological Sciences Faculty Research and
Publications Biological Sciences, Department of
3-1-2017
Two Adjacent Phenylalanines In the NMDA
Receptor GluN2A Subunit M3 Domain
Interactively Regulate Alcohol Sensitivity and Ion
Channel Gating
Hong Ren
Huazhong University of Science and Technology
Yulin Zhao
Marquette University, yulin.zhao@marquette.edu
Man Wu
Mount Sinai School of Medicine
Donard S. Dwyer
Louisiana State University - Shreveport
Robert W. Peoples
Marquette University, robert.peoples@marquette.edu
NOTICE: this is the author’s version of a work that was accepted for publication in
Neuropharmacology. Changes resulting from the publishing process, such as peer review, editing,
corrections, structural formatting, and other quality control mechanisms may not be reflected in this
document. Changes may have been made to this work since it was submitted for publication. A
definitive version was subsequently published in Neuropharmacology, Vol. 114 (March 1, 2017): pgs.
20-33. DOI. © 2017 Elsevier. Used with permission.
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 114 (March 2017): pg. 20-31. DOI. This article is © Elsevier and permission has been granted for 
this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
1 
 
 
 
Two Adjacent Phenylalanines In the 
NMDA Receptor GluN2A Subunit 
M3 Domain Interactively Regulate 
Alcohol Sensitivity and Ion Channel 
Gating 
 
 
 
Hong Ren 
Department of Neurology, Union Hospital, Tongji Medical 
College, Huazhong University of Science and Technology, 
Wuhan, China 
Yulin Zhao 
Laboratory of Membrane Excitability and Disease Mount Sinai 
School of Medicine, 
New York, NY 
Man Wu 
Department of Neuroscience, University of Pittsburgh, 
Pittsburgh, PA 
Donard S. Dwyer 
Department of Psychiatry, 
Louisiana State University Health Sciences Center, 
Shreveport, LA 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 114 (March 2017): pg. 20-31. DOI. This article is © Elsevier and permission has been granted for 
this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
2 
 
Robert W. Peoples 
Department of Biomedical Sciences, Marquette University, 
Milwaukee, WI 
 
 
 
 
Abstract: The N-methyl-d-aspartate (NMDA) receptor is a key target of 
ethanol action in the central nervous system. Alcohol inhibition of NMDA 
receptor function involves small clusters of residues in the third and fourth 
membrane-associated (M) domains. Previous results from this laboratory 
have shown that two adjacent positions in the M3 domain, F636 and F637, 
can powerfully regulate alcohol sensitivity and ion channel gating. In this 
study, we report that these positions interact with one another in the 
regulation of both NMDA receptor gating and alcohol action. Using dual 
mutant cycle analysis, we detected interactions among various substitution 
mutants at these positions with respect to regulation of glutamate EC50, 
steady-state to peak current ratios (Iss:Ip), mean open time, and ethanol IC50. 
This interaction apparently involves a balancing of forces on the M3 helix, 
such that the disruption of function due to a substitution at one position can 
be reversed by a similar substitution at the other position. For example, 
tryptophan substitution at F636 or F637 increased or decreased channel mean 
open time, respectively, but tryptophan substitution at both positions did not 
alter open time. Interestingly, the effects of a number of mutations on 
receptor kinetics and ethanol sensitivity appeared to depend upon subtle 
structural differences, such as those between the isomeric amino acids leucine 
and isoleucine, as they could not be explained on the basis of sidechain 
molecular volume or hydrophilicity. 
Keywords: Glutamate, Ion channel, Ethanol 
1. Introduction 
Ethyl alcohol, or ethanol, causes a range of behavioral effects 
including ataxia and impaired cognition, and is widely abused, 
contributing to over 5% of all diseases and injuries worldwide (World 
Health Organization, 2014). Although ethanol produces its effects in 
the brain by acting on multiple target proteins (Vengeliene et al., 
2008), one of the most important of these targets is the NMDA 
receptor. The NMDA receptor is a glutamate-gated ion channel most 
commonly composed of GluN1 and GluN2(A-D) subunits, with 
allosteric sites for several endogenous modulators located in the 
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extracellular N-terminal domain, and multiple sites for phosphorylation 
and interaction with intracellular proteins located in the C-terminal 
domain (Traynelis et al., 2010). Although NMDA receptor ethanol 
sensitivity can be modulated by sites in both the N-terminal and C-
terminal domains (Smothers et al., 2013 and Woodward, 2000), the 
primary site of ethanol action is not located in either of these regions, 
because removal of the C-terminus does not abolish or decrease 
ethanol inhibition (Peoples and Stewart, 2000), and the influence of 
sites in the N-terminus on ethanol sensitivity is subtle (Smothers 
et al., 2013). Furthermore, although glycine concentration can in some 
cases modulate ethanol inhibition, ethanol does not act at the agonist 
binding domains for glutamate or glycine (Woodward, 
2000 and Peoples, 2003). Ethanol appears to inhibit NMDA receptor 
function via specific amino acids in the M3 and M4 domains (Ronald 
et al., 2001, Ren et al., 2003b, Ren et al., 2007, Ren et al., 2012, Ren 
et al., 2013, Honse et al., 2004, Smothers and Woodward, 
2006 and Zhao et al., 2015), as mutations at these positions 
powerfully regulate, and in some cases can essentially eliminate, 
ethanol sensitivity (Ren et al., 2012). The M3 domain forms the upper 
part of the ion channel lumen and is essential for gating of the ion 
channel (Kohda et al., 2000, Jones et al., 2002 and Sobolevsky et al., 
2002), and the M4 domain also influences gating (Ren et al., 
2003a and Schorge and Colquhoun, 2003), likely by interacting with 
M3. Ethanol acts by altering NMDA receptor gating, by decreasing ion 
channel mean open time and opening frequency (Wright et al., 1996). 
Thus, alcohol inhibits the NMDA receptor by biasing the ion channel 
toward the closed state. We consider it likely that alcohol does so by 
binding in or near the clusters of alcohol-sensitive positions in the M3 
and M4 domains, because mutations at these positions can profoundly 
alter alcohol sensitivity. For example, mutation of only two of these 
positions, one each in the GluN1 and GluN2A subunits, results in an 
ethanol IC50 value of over 1 M (Ren et al., 2012). 
Of the alcohol-sensitive residues in M3 and M4 of GluN1/GluN2A 
NMDA receptors, mutations at two phenylalanines in the GluN2A M3 
domain, F636 and F637, have the greatest effect on alcohol inhibition 
(Ren et al., 2012 and Ren et al., 2013). Recent studies have shown 
that these positions and positions in the GluN1 M4 subunit interact to 
regulate both ion channel gating and alcohol sensitivity (Ren et al., 
2012 and Xu et al., 2015). In the present study we report that the side 
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chains at positions 636 and 637 in M3 interact with one another in the 
regulation of ion channel kinetics and alcohol inhibition. In addition, for 
some substituents there is an apparent balancing effect between the 
two positions, such that the changes in ion channel gating and ethanol 
sensitivity caused by a substitution at one position can be reversed by 
an identical substitution at the adjacent position. 
2. Materials and methods 
2.1. Materials 
Ethanol (95%, prepared from grain) was obtained from Aaper 
Alcohol & Chemical Co. (Shelbyville, KY, USA), and all other drugs and 
chemicals were obtained from Sigma Chemical Co. (St. Louis, MO, 
USA). 
2.2. Site-directed mutagenesis, cell culture, and 
transfection 
Site-directed mutagenesis in plasmids containing GluN2A 
subunit cDNA was performed using the QuikChange II kit (Stratagene, 
La Jolla, CA, USA), and all mutants were verified by double-stranded 
DNA sequencing. Human embryonic kidney (HEK) 293 cells obtained 
from the American Type Culture Collection (Manassas, VA) were 
cultured as previously described (Ren et al., 2012), with minor 
modifications. Cells were cultured in an incubator at 37 °C in 5% CO2 
in DMEM containing 10% heat-inactivated fetal bovine serum, Earle's 
salts, non-essential amino acids, sodium pyruvate, and l-glutamine. 
Cells were allowed to grow to 50–90% confluence, and were 
suspended with EDTA-trypsin. Suspended cells were plated at low 
density in 35-mm poly-d-lysine coated dishes and transfected with 
cDNA for the GluN1 and wild-type or mutant GluN2A subunits and 
green fluorescent protein (pGreen Lantern; Invitrogen, Carlsbad, CA) 
at a ratio of 2:2:1 using a calcium phosphate transfection kit 
(Invitrogen). The NMDA receptor antagonists dl-2-amino-5-
phosphonovaleric acid (APV), 200 μM, ketamine, 100 μM, or MgCl2, 
1 mM, were added to the culture medium of each dish to protect cells 
from receptor-mediated excitotoxicity post-transfection. Recordings 
were made within 48 h following transfection. 
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2.3. Electrophysiological recording 
Transfected cells were extensively washed to remove NMDA 
receptor antagonists before use in experiments. Patch-clamp recording 
was performed at room temperature using an Axopatch 1D or 
Axopatch 200B (Molecular Devices, Sunnyvale, CA, USA) amplifier. For 
whole-cell recordings, patch pipettes pulled from thin-walled glass 
capillaries with open tip resistances of 1–6 MΩ were used; GΩ seals 
were formed and series resistances of 2–8 MΩ were compensated by 
80%. For single-channel recordings, patch pipettes pulled from thick-
walled glass capillaries with tip resistances of 8–20 MΩ were fire 
polished and coated with R6101 elastomer (Dow-Corning). Cells were 
voltage-clamped at −50 mV and superfused in an external recording 
solution containing (in mM): 150 NaCl, 5 KCl, 0.2 CaCl2, 10 HEPES, 10 
glucose, and 10 sucrose (pH 7.4). Low calcium was used to minimize 
calcium-dependent inactivation (Zilberter et al., 1991). In glutamate 
concentration-response experiments, glycine, 50 μM, was added to the 
external solution to saturate the glycine binding site, EDTA, 10 μM, 
was added to minimize Zn2+ -dependent desensitization (Erreger and 
Traynelis, 2005), and cells were lifted off the surface of the dish to 
increase the speed of the solution exchange. Under these conditions 
10–90% rise times for solution exchange are ∼1.5 ms. The 
intracellular recording solution in whole-cell experiments contained (in 
mM): 140 CsCl, 2 Mg4ATP, 10 BAPTA, and 10 HEPES (pH 7.2). 
Solutions of agonists and ethanol were applied to cells using a stepper 
motor-driven solution exchange apparatus (Warner Instruments, 
Hamden, CT, USA) and 600 μm id square glass tubing. 
Data from whole-cell recordings were filtered at 2 kHz (8-pole 
Bessel) and acquired at 5 kHz on a computer using a DigiData 
interface and pClamp software (Molecular Devices). Single-channel 
data were filtered at 10 kHz (8-pole Bessel) and acquired at 50 kHz. 
2.4. Data analysis 
In concentration-response experiments, IC50 or EC50 and n 
(slope factor) were calculated using the equation: y = Emax/1 + (IC50 or 
EC50/x)n, where y is the measured current amplitude, x is 
concentration, n is the slope factor, and Emax is the maximal current 
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amplitude. A complete concentration-response curve was obtained 
from each cell, and log-transformed EC50 or IC50 values calculated from 
curve fits from individual cells containing mutant subunits were 
compared to those for wild-type subunits using one-way ANOVA 
followed by the Dunnett test. Linear relations of mean values of log 
EC50, log IC50, or maximal steady-state to peak current ratio (Iss:Ip) for 
the various mutant subunits were tested using linear regression 
analysis. All values are reported as the mean ± S.E. 
Data from single-channel recordings were idealized using the 
segmentation K-means algorithm in the QUB software suite (Qin, 
2004). Dwell time histograms were fitted with two or three exponential 
components using ChannelLab software and mean open times were 
obtained from the proportionally weighted averages of the individual 
components. Data were obtained from 5 to 22 patches for each 
GluN2A receptor mutant tested. 
The apparent interaction free energies (ΔΔGINT) between amino 
acid side chains in dual mutants were calculated from natural 
logarithm-transformed values of glutamate EC50, mean open time, and 
ethanol IC50 values using the equation: 
ΔΔGINT = RT[ln(WT) + ln(mut1,mut2) − ln(mut1) − ln(mut2)], where 
R is the gas constant and T is the temperature in degrees Kelvin 
(Venkatachalan and Czajkowski, 2008). Mean values of ΔΔGINT ± S.E. 
were analyzed for statistically significant differences from zero energy 
using one-sample t tests with degrees of freedom 
df = NWT + NMUT1 + NMUT2 + NMUT1,MUT2 − 4, where NX was the number of 
cells used for wild-type and mutant receptors and S.E. was determined 
from propagated errors. Values for mutants containing single 
substitutions of alanine, isoleucine, or tryptophan at F636 or F637 are 
those reported previously ( Ren et al., 2007 and Ren et al., 2013). 
 
Fig. 1. Alignment of M3 domains in GluN1 and GluN2 subunits. Sequences of the M3 
domains in GluN1 and GluN2A-D subunits are shown, with positions F636 and F637 in 
the GluN2A subunit in bold type and underlined. 
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3. Results 
3.1. Effects of dual mutations at F636 and F637 in M3 
of the GluN2A subunit on glutamate potency and 
desensitization 
As we have previously reported, both F636 and F637 in the 
GluN2A subunit M3 domain (Fig. 1) regulate NMDA receptor function 
(Ren et al., 2007, Ren et al., 2012 and Ren et al., 2013). To determine 
whether these two positions might interactively influence NMDA 
receptor kinetics, we constructed and tested a series of dual 
substitution mutants at these positions. All tested dual mutant 
combinations were functional, with no obvious differences in receptor 
kinetics other than changes in current amplitude (Table 1) and 
macroscopic desensitization in some cases (Fig. 2A). Concentration-
response curves among the various mutant subunits were essentially 
parallel (Fig. 2B), as none of the mutations changed the Hill coefficient 
(p > 0.05; ANOVA, data not shown). A number of mutant subunit 
combinations shifted concentration-response curves for glutamate-
activated peak and steady-state currents to either the right or left 
(Fig. 2B and C), altering EC50 values for glutamate peak (ANOVA; 
p < 0.0001; Fig. 3A) and steady-state currents (ANOVA; p < 0.0001; 
Fig. 3B). Four of the seven mutant subunits tested decreased 
glutamate peak and steady-state current EC50 values (ANOVA and 
Dunnett's test; p < 0.05, p < 0.01; Fig. 3A and B), whereas the only 
increase observed was in the glutamate EC50 for steady-state current 
in the GluN2A(F636A/F637A) mutant. In previous studies, we found 
that single substitution mutations at either F636 or F637 in the M3 
domain of the GluN2A subunit showed a strong correlation between 
peak and steady-state EC50 values ( Ren et al., 2007 and Ren et al., 
2013). In the present study, we observed a similar correlation for dual 
mutants at these positions (R2 = 0.930, p < 0.0001; Fig. 3C). 
Table 1. Current amplitudes of GluN2A(F636/F637) mutants. 
Substituent at F636/F637 Ipeak (pA) Isteady-state (pA) n 
F/F (WT) 3580 ± 1010 2080 ± 538 13 
A/F 2170 ± 683 2040 ± 630 5 
C/F 2280 ± 840 1830 ± 617 6 
I/F 947 ± 375*F/A, I/I 865 ± 336*I/I 6 
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Substituent at F636/F637 Ipeak (pA) Isteady-state (pA) n 
L/F 1790 ± 805 1280 ± 578 5 
W/F 893 ± 261 825 ± 234*I/I 5 
F/A 6090 ± 2120 2840 ± 860 6 
F/C 1540 ± 425*F/A, I/I 771 ± 226*C/C,**I/I 9 
F/I 1950 ± 835 711 ± 298*C/C,**I/I 6 
F/W 928 ± 333*F/A, I/I 709 ± 262*C/C,**I/I 6 
A/A 1380 ± 452 1250 ± 362 6 
A/W 4100 ± 1070 3040 ± 754 6 
C/C 5610 ± 1150 3430 ± 622 7 
I/I 6520 ± 1330 4100 ± 884 5 
L/L 642 ± 182*C/C, F/A, I/I 415 ± 105*C/C, **I/I 6 
W/A 3000 ± 1040 2100 ± 700 6 
W/W 1010 ± 384*I/I 886 ± 320*I/I 6 
The single-letter code F for phenylalanine is shown in italic typeface to denote that it is 
the native residue at either position; mutated residues are shown in bold typeface. 
Asterisks indicate significant differences from the current amplitudes of the indicated 
mutants (ANOVA and Tukey/Kramer test; *p < 0.05, **p < 0.01). None of the current 
amplitudes differed from that of the wild-type receptor (ANOVA and Dunnett's test; 
p > 0.05). 
 
Fig. 2. Dual mutations at F636 and F637 in the M3 domain of the GluN2A subunit 
influence both peak and steady-state glutamate EC50values. A, Traces are currents 
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activated by 300 μM glutamate in the presence of 50 μM glycine in lifted HEK 293 cells 
expressing wild-type GluN1/GluN2A (WT) or various GluN1/GluN2A(F636/F637) 
mutant subunits. Labels indicate mutations at 636/637 using single-letter amino acid 
codes. B-C, Concentration-response curves for glutamate-activated peak (Ip) and 
steady-state (Iss) currents in the presence of 50 μM glycine in lifted HEK 293 cells 
expressing wild-type GluN1/GluN2A (WT) or various GluN1/GluN2A(F636/F637) 
mutant subunits. Data points are the means ± S.E. of five to twelve cells, error bars 
not visible were smaller than the size of the symbols, and the curves shown are the 
best fits to the equation given in the “Materials and Methods”. 
 
Fig. 3. Comparison of glutamate potency and desensitization among GluN2A 
F636/F637 dual mutant subunits. A-B, Bar graphs show the average EC50 values for 
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glutamate-activated peak (Ip, A) and steady-state (Iss, B) currents in lifted HEK 
293 cells expressing GluN1 and wild-type GluN2A subunits (F/F, gray) or various 
GluN1/GluN2A(F636/F637) mutant subunits. Asterisks indicate EC50 values that 
differed from the wild-type value (***P < 0.001; one-way ANOVA). Results are the 
means ± S. E of 5–12 cells. C, Graph plots values of glutamate log EC50 for peak 
current in the series of mutants versus values of glutamate log EC50 for steady-state 
current; these values were significantly correlated (R2 = 0.93, P < 0.001). The line 
shown is the least-squares fit to the data. D, Bar graph shows the average values of 
maximal steady-state to peak current ratio (Iss:Ip) in lifted cells coexpressing GluN1 
and wild-type GluN2A subunits (F/F, gray) or various GluN1/GluN2A(F636/F637) 
mutant subunits. Currents were activated by 300 μM glutamate in the presence of 
50 μM glycine. Asterisks indicate values that differed significantly from the wild-type 
value (*P < 0.05, **P < 0.01; one-way ANOVA). Results are the means ± S. E of 5–
12 cells. 
Dual mutations at GluN2A(F636/F637) altered macroscopic 
desensitization as assessed by steady-state to peak current ratio 
(Iss:Ip; ANOVA, p < 0.0001; Fig. 3D). Five of seven dual mutants 
tested increased Iss:Ip values compared to that of the wild-type 
subunits (ANOVA and Dunnett's test; p < 0.05 or p < 0.01; Fig. 3D), 
and the remaining mutants did not alter Iss:Ip values. Although both 
glutamate potency and apparent desensitization were changed by 
mutations at GluN2A(F636/F637), maximal Iss:Ip values were not 
correlated with either glutamate peak or steady-state EC50 values 
(r2 = 0.0030 and r2 = 0.076 for peak and steady-state current EC50, 
respectively; correlation analysis; p > 0.05; Fig. 3E–F). 
3.2. Effects of dual mutations at GluN2A F636 and F637 
on NMDA receptor mean open time 
Previous studies from this laboratory have shown that both 
GluN2A(F636) and GluN2A(F637) regulate ion channel gating (Ren 
et al., 2007 and Ren et al., 2013). To investigate whether dual 
mutations at these positions can interact to modulate mean open time, 
we tested the effect of selected mutants on mean open time by using 
single-channel recording in outside-out patches (Fig. 4 and Table 2). 
Open time distributions in cells expressing wild-type GluN1 and 
GluN2A subunits (Fig. 4A and B) were best fitted with two exponential 
components with average time constants of 0.10 ± 0.0077 ms (37%) 
and 4.5 ± 0.23 ms (63%; n = 22 patches), yielding a mean open time 
of 3.4 ± 0.21 ms. The open time distributions in cells expressing 
F636W mutant subunits (Fig. 4C and D) also were best fitted with two 
exponential components with average time constants of 
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0.27 ± 0.032 ms (11%) and 15 ± 1.7 ms (89%; n = 10 patches). The 
mean open time of 14 ± 1.6 ms in F636W mutant subunits was over 
four times that in wild-type receptors (ANOVA and Dunnett's test, 
p < 0.001). Open time distributions for the GluN2A(F637W) mutation 
( Fig. 4E and F) were best fitted with two exponential components with 
average time constants of 0.12 ± 0.0094 ms (65%) and 
0.97 ± 0.13 ms (35%; n = 9 patches). In contrast to GluN2A(F636W), 
the mean open time of 0.51 ± 0.055 ms in the GluN2A(F637W) 
subunit was less than one-sixth of the value in the wild-type subunit 
(ANOVA and Dunnett's test; p < 0.001). The dual mutant 
GluN2A(F636W/F637W) subunit (Fig. 4G, H) could be fitted with two 
time constant values of 0.17 ± 0.010 ms (39%) and 4.6 ± 0.38 ms 
(61%; n = 6 patches). Interestingly, mean open time in the dual 
tryptophan mutant subunit was 3.2 ± 0.36 ms (n = 6), which was not 
different from the value of 3.4 ± 0.21 ms (n = 22) in the wild-type 
GluN1/GluN2A receptor (ANOVA and Dunnett's test, p > 0.05). Mutant 
subunits bearing dual isoleucine substitutions at these positions had 
decreased mean open times ( Table 2; ANOVA; p < 0.01). Mean open 
time was also decreased in the dual alanine mutant 
GluN2A(F636A/F637A) as well as in the GluN2A(F636A/F637W) 
mutant ( Table 2; ANOVA; p < 0.01), but was unchanged in 
GluN2A(F636W/F637A) subunits ( Table 2; ANOVA; p > 0.05). 
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Fig. 4. Tryptophan mutations at F636 and F637 positions interactively regulate mean 
open time of the NMDA receptor. Traces (A, C, E, G) and open time distributions (B, D, 
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F, H) of single-channel currents activated by 100 nM −1 μM glutamate and 50 μM 
glycine in outside-out patches from cells expressing wild-type GluN1 subunits and 
GluN2A wild-type (A,B), F636W (C,D), F637W (E,F), or F636W/F637W (G,H) mutant 
subunits. Open time distributions were fitted with two exponential components; 
average values of τ and percentage for all patches are given in the text. Traces and 
corresponding open time distributions were from the same outside-out patches. 
Similar results were obtained in 5–21 additional patches for each subunit combination. 
 
Table 2. Mean open times in GluN2A(F636/F637) mutants. 
Substituents at GluN2A(F636/F637) Mean open time (ms) N 
WT (F/F) 3.4 ± 0.21 22 
A/F 3.1 ± 0.42 5 
F/A 0.82 ± 0.084*** 6 
A/A 0.77 ± 0.034 *** 5 
I/I 1.4 ± 0.25** 5 
W/F 14 ± 1.6*** 10 
F/W 0.51 ± 0.055*** 9 
W/W 3.2 ± 0.36 6 
A/W 0.81 ± 0.080*** 5 
W/A 3.2 ± 0.47 6 
WT(F/F), wild-type. Values are the means ± S.E. obtained from 5 to 22 patches. 
Significant differences from values obtained for the wild-type receptor (ANOVA and 
Dunnett's test; **p < 0.01, ***p < 0.001). Values for wild-type, A/F, and W/F 
receptors are from Ren et al. (2013). 
3.3. Effects of dual mutations at GluN2A F636 and F637 
on NMDA receptor ethanol sensitivity 
We have previously reported that four pairs of positions at the 
intersubunit interfaces of the M3 and M4 domains of the GluN1 and 
GluN2A subunits interactively regulate ethanol sensitivity (Ren et al., 
2012). In these studies, we tested the effect of dual mutations at 
GluN2A F636 and F637 in regulating NMDA receptor ethanol inhibition 
using concentration-response analysis. All GluN2A mutants were 
inhibited by ethanol in a concentration-dependent manner (Fig. 5B). 
Ethanol sensitivity was altered in four of seven mutant subunits 
(Fig. 5C): IC50 values were decreased in the dual alanine and dual 
cysteine mutants (ANOVA and Dunnett's test; p < 0.05), but were 
increased in the dual isoleucine and F636A/F637W mutants (ANOVA 
and Dunnett's test; p < 0.01). Interestingly, ethanol sensitivity was 
unchanged in the dual leucine and tryptophan mutant subunits 
(ANOVA and Dunnett's test; p > 0.05). 
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Fig. 5. Dual mutations at GluN2A(F636/F637) can alter NMDA receptor ethanol 
sensitivity. A, Traces are currents activated by 10 μM glutamate and 50 μM glycine 
and their inhibition by 100 mM ethanol (EtOH) in cells expressing GluN1 and GluN2A 
wild-type (F/F) or 636/637 mutant subunits. B, Concentration-response curves for 
ethanol inhibition of glutamate-activated current in cells expressing various 
substitution mutations at GluN2A(F636/F637). Data are the means ± S.E. of 5–
12 cells; error bars not visible were smaller than the size of the symbols. Curves 
shown are the best fits to the equation given in the Materials and Methods. The black 
curve shows the fit for the wild-type GluN2A subunit. C, Bar graph shows the average 
IC50 values for ethanol inhibition of glutamate-activated current in cells expressing 
GluN1 and wild-type GluN2A subunits (F/F) or GluN2A subunits containing various 
mutations at F636 and F637. Asterisks indicate IC50 values that are significantly 
different from the wild-type value (*P < 0.05; **P < 0.01; one-way ANOVA). Results 
are the means ± S. E of 5–12 cells. The wild-type value is from Ren et al. (2012). 
3.4. Interactions between GluN2A F636 and F637 on 
NMDA receptor ion channel function and ethanol 
sensitivity 
To determine whether GluN2A F636 and F637 could functionally 
interact to regulate NMDA receptor ion channel function and ethanol 
sensitivity, we performed two-way interaction analysis of variance and 
mutant cycle analysis on concentration-response and single-channel 
data among the substitution mutants at these two positions. Both two-
way analysis of variance and mutant cycle analysis detected strong 
interactions between the positions in regulating glutamate peak EC50 
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values (Fig. 6, Table 3) for substitution of alanine, cysteine, or 
tryptophan (p < 0.0001), and an apparently weaker interaction for 
substitution of isoleucine (p < 0.05). Similar results were obtained for 
glutamate steady-state EC50 values (Table 3). GluN2A positions 636 
and 637 also interacted with respect to regulation of mean open time 
in tryptophan substitution mutants (Fig. 7), as indicated by both types 
of analysis (p < 0.05). Although a majority of the mutant subunits 
altered values of Iss:Ip, an interaction between GluN2A 636 and 637 
was detected only in the leucine mutants (Table 3). We also tested for 
the presence of functional interactions between the positions with 
respect to regulation of ethanol inhibition (Fig. 8; Table 3). Despite the 
marked decrease in ethanol sensitivity in the GluN2A(F636I) mutant, 
no functional interaction between positions 636 and 637 was detected 
for regulation of ethanol IC50 by isoleucine substitutions using either 
type of analysis (p > 0.05). In contrast, both two-way analysis of 
variance and mutant cycle analysis indicated functional interactions 
with respect to ethanol sensitivity for alanine mutants (p < 0.05), as 
well as cysteine and tryptophan mutants (p < 0.0001) at these 
positions. 
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Fig. 6. Positions F636 and F637 in the GluN2A subunit interactively regulate glutamate 
apparent potency. A-D, Graphs plot Ip EC50 values for glutamate versus the 
substituent at F637 position for various mutants at position F636. Asterisks indicate 
that interaction free energy (ΔΔGINT) values are significantly different from zero energy 
(*, P < 0.05; ****, P < 0.0001). E-F, Mutant cycle analysis of glutamate Ip EC50 
values in dual isoleucine and tryptophan mutations at GluN2A F636/F637. Apparent 
free energy values associated with the various mutations (ΔGx) are given in kcal 
mol−1. Values of ΔΔGINT are the means ± S. E. (*, P < 0.05; ****, P < 0.0001). The 
equation used to calculate ΔΔGINT is given in the Materials and Methods. 
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Table 3. Mutant cycle analysis of glutamate Ip EC50, Iss EC50, Iss:Ip, and 
ethanol IC50. 
Mutant 
(F636/F6
37) 
Ip EC50 
 
Iss EC50 
 
Iss:Ip 
 
Ethanol IC50 
 
ΔΔGINT d
f 
ΔΔGINT d
f 
ΔΔGINT d
f 
ΔΔGINT d
f 
A/A 0.44 ± 0.094*
*** 
2
4 
0.47 ± 0.10**
** 
2
4 
0.082 ± 0.07
9 
2
5 
−0.19 ± 0.071
* 
2
3 
C/C −0.24 ± 0.054
**** 
2
7 
−0.32 ± 0.067
**** 
2
7 
−0.13 ± 0.06
4 
2
8 
−0.30 ± 0.056
**** 
2
0 
I/I 0.33 ± 0.14* 2
4 
0.42 ± 0.11** 2
4 
−0.043 ± 0.0
62 
2
4 
−0.030 ± 0.06
1 
2
0 
L/L 0.043 ± 0.089 2
5 
0.055 ± 0.13 2
5 
0.46 ± 0.081
**** 
2
5 
−0.12 ± 0.054
* 
2
3 
W/W 0.85 ± 0.14**
** 
2
5 
0.89 ± 0.11**
** 
2
5 
−0.091 ± 0.0
48 
2
5 
−0.88 ± 0.065
**** 
2
3 
Ip: peak current; Iss: steady-state current; Iss/Ip: maximal peak to steady-state 
current ratio; ΔΔGINT: interaction free energy; df: degrees of freedom. 
Values for ΔΔGINT are means ± S.E in kcal mol−1. Asterisks indicate significant 
differences from zero energy (one sample t-test as described in the Materials and 
Methods; *p < 0.05, **p < 0.01, ****p < 0.0001). Values for wild-type and single 
mutations used in calculations are from Ren et al., 2007 and Ren et al., 2013. 
 
 
Fig. 7. Positions F636 and F637 in the GluN2A subunit interactively regulate ion 
channel mean open time. A, Graph plots the mean open time values (in ms) versus 
the substituent at F637 for the substituent at position F636. Asterisks indicate that 
interaction free energy (ΔΔGINT) values are significantly different from zero energy (*, 
P < 0.05). B, Mutant cycle analysis of mean open time for dual tryptophan mutants at 
GluN2A F636/F637. Apparent free energy values associated with the various mutations 
(ΔGx) are given in kcal mol−1. Values of ΔΔGINT are the means ± S. E. (*, P < 0.05). 
The equation used to calculate ΔΔGINT is given in the Materials and Methods. 
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Fig. 8. Positions F636 and F637 in the GluN2A subunit interactively regulate ethanol 
sensitivity. A-D, Graphs plot IC50 values for ethanol versus the substituent at F637 for 
various mutants at position F636. Asterisks indicate that interaction free energy 
(ΔΔGINT) values are significantly different from zero energy (*, P < 0.05; ****, 
P < 0.0001). E-F, Mutant cycle analysis of ethanol IC50 values in dual isoleucine and 
tryptophan mutations at GluN2A F636/F637. Apparent free energy values associated 
with the various mutations (ΔGx) are given in kcal mol−1. Values of ΔΔGINT are the 
means ± S. E. (****, P < 0.0001). The equation used to calculate ΔΔGINT is given in 
the Materials and Methods. 
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4. Discussion 
Previous studies from this laboratory have found that two 
adjacent phenylalanines at positions 636 and 637 in M3 domain of the 
NMDA receptor GluN2A subunit can regulate ion channel gating and 
ethanol action (Ren et al., 2007, Ren et al., 2012 and Ren et al., 
2013). The results of the present study provide evidence that these 
residues can interact with each other to regulate receptor function, 
such that the side chain at one position alters the influence of the side 
chain at the adjacent position on ethanol sensitivity and ion channel 
gating. 
We observed marked differences in maximal amplitudes of 
glutamate-activated current in the present study. The changes in 
current amplitude observed among mutants could arise from changes 
in open probability, as we have observed for a position in the M4 
domain (Ren et al., 2003a). Of particular interest, the maximal 
glutamate-activated current in cells expressing the F636I/F637I 
mutant was ten-fold larger than that in cells expressing the 
F636L/F637L mutant. This difference, however, does not appear to be 
attributable to differences in ion channel gating. Although we do not 
have single-channel data for the F636L/F637L mutant, the current 
amplitude in cells expressing the wild-type channel was approximately 
half that of cells expressing the F636I/F637I mutant, whereas the 
mean open time (Table 2) and open probability (data not shown) of 
the wild-type channel were both approximately twice that of the 
F636I/F637I mutant. It thus appears most likely that the observed 
changes in current amplitude among the mutants in the present study 
are largely attributable to variations in receptor density due to factors 
such as transfection efficiency. 
The majority of mutant combinations at GluN2A(F636/F637) 
tested altered glutamate EC50 values for both peak and steady-state 
current. We and others have previously shown that single mutations at 
either position can affect glutamate potency in the GluN2A subunit 
(Ren et al., 2007, Ren et al., 2012 and Ren et al., 2013), and 
mutations at GluN1(F639), one of the corresponding positions in the 
GluN1 subunit, can affect glycine potency (Ronald et al., 
2001 and Smothers and Woodward, 2006). These changes in 
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glutamate apparent affinity are attributable to changes in ion channel 
gating that reciprocally affect agonist binding (Colquhoun, 
1998 and Ren et al., 2007), as has been shown for mutations at other 
positions in or near the M3 domain in AMPA and NMDA receptors (Klein 
and Howe, 2004; Kohda et al., 2000, Yelshansky et al., 
2004 and Harms et al., 2014). As was the case for both of the 
individual positions, peak and steady-state EC50 values were highly 
correlated among dual mutants at F636/F637, suggesting that peak 
and steady-state current were similarly affected by the changes in 
gating produced by the mutations. Desensitization, as assessed using 
Iss:Ip, was altered in five of the seven dual mutants tested, but was not 
correlated with steady-state EC50 values. Furthermore, macroscopic 
desensitization in these five mutants was decreased, whereas 
glutamate affinity was increased in three of these five mutants. These 
results, taken together with the strong correlation between peak and 
steady-state glutamate EC50 values, suggests that increases in 
glutamate affinity in the dual mutants were not due to trapping of 
agonist in a desensitized state of the receptor, as was observed for 
single mutations at GluN2A(M823) in the M4 domain (Ren et al., 
2003a). Similarly, changes in glutamate affinity observed in the dual 
mutants do not appear to be due to changes in mean open time, 
because glutamate potency was increased in GluN2A mutants in which 
mean open time was prolonged (F636W), shortened (F637W), or 
unchanged (F636W/F637W). The precise changes in ion channel gating 
responsible for the alterations in glutamate affinity are unclear at 
present, and could well differ for the two positions. 
Although the changes in glutamate affinity that we observed 
among mutants at GluN2A positions F636 and F637 are likely due to 
altered ion channel gating, we also observed that these positions could 
interact in the regulation of mean open time, a direct measure of ion 
channel gating. Previous studies from this laboratory reported that 
substitution of various amino acids at either position could alter mean 
open time. For example, at GluN2A(F636), mean open time was 
unchanged by alanine substitution but increased over four-fold by 
tryptophan substitution (Ren et al., 2013), whereas at GluN2A(F637), 
mean open time was decreased significantly by either alanine or 
tryptophan substitution (Ren et al., 2007). The conformational 
changes associated with opening of the NMDA receptor ion channel 
pore are not known at present, but likely involve rotation and tilting of 
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the M3 helices away from the central axis of the pore (Karakas and 
Furukawa, 2014, Kazi et al., 2013 and Sobolevsky, 2015). Because 
mean open time of an ion channel reflects its closing rate (Hille, 
2001), tryptophan substitution at GluN2A(F636) stabilizes, and alanine 
or tryptophan substitution at GluN2A(F637) destabilizes, the open 
state. Stabilization of the open state by GluN2A(F636W) may involve 
either strengthening of interactions that delay closing or weakening of 
interactions that promote closing, or both, while the reverse may be 
true of GluN2A(F637A) and GluN2A(F637W). A possible molecular 
basis for these observations is illustrated in Fig. 9. Based on the 
structure of the closed GluN1/GluN2B receptor (Karakas and 
Furukawa, 2014), the native phenylalanine at 636 is surrounded by 
hydrophobic side chains from the GluN1 subunit M2 domain: two 
leucine residues at 614–615, with which it may form hydrophobic 
interactions, and a tryptophan residue at 611, with which it may form 
an aromatic bond. Introduction of an alanine at this position would be 
predicted to decrease the strength of hydrophobic interactions and 
eliminate the aromatic bond, whereas introduction of a tryptophan, 
provided that its additional molecular volume could be accommodated, 
could strengthen these interactions. The changes in gating associated 
with these mutations may indicate that weakening the interactions at 
GluN2A position 636 does not influence open time, but strengthening 
of these interactions slows the closing rate. The native phenylalanine 
at 637 in GluN2A is surrounded by the side chains of a phenylalanine 
at 817 and two valine residues at 816 and 820 from the GluN1 M4 
domain, as well as a methionine at 564 in the GluN2A M1 domain. An 
alanine substitution at 637 would likely greatly reduce the strength of 
hydrophobic interactions with the GluN1 M4 side chains, which may 
account for the decrease in mean open time. The apparently 
paradoxical observation that tryptophan substitution at 637, which 
would be predicted to increase the strength of hydrophobic 
interactions, also decreases mean open time may be explained by a 
steric clash with the methionine at 564. Although full resolution of the 
molecular mechanisms underlying these observations will likely require 
the solution to the structure of the M domains in the open state, 
further mutagenesis studies should be able to give important insights 
into this question. 
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Fig. 9. Altered interactions of phenylalanine side chains at GluN2A positions 636 and 
637 with hydrophobic side chains from adjacent helices may explain effects of alanine 
and tryptophan mutations on mean open time. A, The environment around the 
phenylalanine at GluN2A 636 (purple) includes two leucine residues at 614–615 and a 
tryptophan residue at 611 from the GluN1 M2 domain (left). Introduction of an alanine 
at 636 (center) may decrease the strength of hydrophobic and aromatic interactions, 
while introduction of a tryptophan (right) could strengthen these interactions. We 
propose that weakening the interactions at GluN2A position 636 does not influence 
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open time, but strengthening these interactions slows the closing rate, prolonging 
open time. B, The environment around the phenylalanine at GluN2A 637 (cyan) 
includes a phenylalanine at 817 and two valine residues at 816 and 820 from the 
GluN1 M4 domain, and a methionine at 564 in the GluN2A M1 domain (left). Alanine 
substitution at 637 may diminish hydrophobic interactions with the GluN1 M4 side 
chains (center), decreasing mean open time. Tryptophan substitution at 637 (right) 
may decrease mean open time by introducing a steric clash with the methionine at 
GluN2A 564. 
Experiments using multiple substituents revealed that the M3 
domain positions GluN2A F636 and F637 interactively regulate 
glutamate potency and mean open time. Dual mutant cycle analysis 
and two-way interaction ANOVA revealed interactions between F636 
and F637 regulating glutamate EC50 values following substitution of 
alanine, cysteine, isoleucine, or tryptophan into one or both positions. 
Although the uncertainty regarding the underlying mechanism by 
which these positions individually regulate glutamate affinity prevents 
a detailed analysis of the molecular mechanism for its interactive 
regulation, the observation that interactions could be detected by 
either decreasing the molecular volume at these positions by alanine, 
cysteine, or isoleucine substitution, or increasing molecular volume by 
tryptophan substitution, suggests a possible role for molecular volume 
of the substituent at these positions (Fig. 9). Interestingly, the 
interaction that appeared to be weakest was that for isoleucine, which 
represented the smallest change in molecular volume among the 
substituents tested compared to the native phenylalanine. We also 
observed interactions with respect to mean open time. Open time 
histograms were fitted with two components corresponding to short 
and long openings, and changes in mean open time in both the 
GluN2A(F636W) and GluN2A(F637W) mutants were attributable to 
changes in the relative proportions and durations of the two 
components. Tryptophan substitution at both positions, however, 
restored mean open time, as well as the durations and relative 
proportions of the two open time components, to the normal ranges 
for the wild-type NMDA receptor. Both mutant cycle analysis and two-
way interaction ANOVA of mean open time values revealed an 
interaction between the positions, but the molecular mechanism 
underlying this interaction is unclear. Because GluN2A F636 and F637 
are adjacent positions in the M3 domain alpha helix, the nature of this 
interaction differs from that of interactions we and others have 
reported between closely apposed side chains on separate M domains 
at intersubunit interfaces (Ren et al., 2012 and Xu et al., 2015). In the 
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latter instance, the distance between the interacting positions, as well 
as their orientation to one another, would change along with 
conformational changes associated with ion channel gating. For 
GluN2A F636 and F637, however, any functional interaction between 
the positions would be dependent upon additional bonds of one or both 
positions with nearby residues on other parts of the protein, as 
discussed above. The presence of these additional bonds appears 
likely, because positions in the M3 domain have been shown to 
interact with multiple positions in the M1 and M2 domains in non-
NMDA glutamate receptors and NMDA receptors (Ogden and Traynelis, 
2013, Lopez et al., 2013, Siegler Retchless et al., 2012, Xu et al., 
2015 and Wilding et al., 2014). We envision the interactions involving 
tryptophan as “balancing” this part of the M3 helix, such that the 
interactions of 636 and 637 with other side chains to alter channel 
closing rate effectively offset each other (Fig. 10A). For example, in 
the dual tryptophan mutant, the increased hydrophobic interactions at 
636 may be opposed by the steric hindrance at 637. It should be 
noted that in this instance, the balancing of the M3 helix would be 
more complex than the simple two-dimensional lateral shift 
represented in Fig. 10. For alanine substitution mutants, however, the 
alteration of mean open times differs from tryptophan mutants. 
GluN2A(F637A) decreased mean open time (Ren et al., 2007), 
whereas GluN2A(F636A) did not alter mean open time (Ren et al., 
2013) or reverse the effect of F637A on mean open time in the 
F636A/F637A dual mutant (Table 2). Furthermore, mutant cycle 
analysis and two-way ANOVA showed that alanine substitutions at 
these two positions do not interact. Similar results were obtained using 
tryptophan and alanine dual mutants: F636A/F637W decreased mean 
open time, but F636W/F637A did not, and these mutants did not 
interact to regulate mean open time (Table 2). These results likely 
indicate the inability of the smaller, aliphatic alanine side chains to 
form hydrophobic or aromatic bonds with other positions to exert the 
effects seen in phenylalanine and tryptophan mutants. 
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Fig. 10. A simple conceptual model for the effects of mutations at F636 and F637 in 
the GluN2A M3 domain. A, The GluN1 M4 domain and GluN2A M3 domain helices are 
shown from the extracellular side; side chains of GluN1 residues M818 and L819 and 
GluN2A residues F636 and F637 are shown. In the wild-type ion channel (left), the 
normal balance of forces at this level of the M3 and M4 helices allows for normal 
gating. Tryptophan substitution at either position 636 or 637 (middle) could alter ion 
channel gating in opposite directions by shifting the M3 helix (blue arrows) in this 
region relative to the GluN1 M4 domain (or by altering the forces on M3 in this region) 
due to interactions with adjacent residues, whereas tryptophan substitution at both 
positions (right) may restore the balance, and with it, normal ion channel gating. The 
wild-type structure is that of the rat GluN1/GluN2B receptor from Karakas and 
Furukawa (2014). The differences in the relative positions of M3 and M4 in the single 
mutants were made by manually shifting the M3 helix relative to M4; these are for the 
purpose of illustration and are not intended to represent actual molecular distances. B, 
The model shown in A with dual isoleucine (left) or leucine (right) substitutions to 
illustrate the subtle differences in structure between these mutants. 
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Although the small number of substituent side chains that we 
tested in the present study precludes a detailed analysis of structural 
features that regulate ion channel gating, the differences observed 
between the effects of the isomeric substituents leucine and isoleucine 
suggest that subtle structural changes at these positions may 
nevertheless have important consequences. In a recent study, we 
found that isoleucine substitution at F636 did not significantly alter 
mean open time, whereas a leucine substitution at the same position 
decreased open time to less than 1 ms (Ren et al., 2013). In contrast, 
in an earlier study, isoleucine substitution at F637 decreased open 
time to approximately 1 ms (Ren et al., 2007). Our observation in the 
present study that the open time in the F636I/F637I mutant was 
1.4 ms is consistent with a greater influence of the substituent at 637 
in this mutant. The molecular mechanism that accounts for the 
observed differences between the leucine and isoleucine mutants is 
not clear, however. Isoleucine and leucine are identical in molecular 
volume and hydrophobicity, so the differences are not attributable to 
simple changes in volume occupation or hydrophobicity irrespective of 
side-chain structure. Multiple hydrophobic side chains from other M 
domains are adjacent to the phenylalanines at 636 and 637 (Karakas 
and Furukawa, 2014), which could allow for aromatic interactions with 
the phenylalanine side-chains (Mahadevi and Sastry, 2013). Either 
leucine or isoleucine substitution, however, would eliminate the phenyl 
ring of the phenylalanine side chain in the native protein, disrupting 
any aromatic interactions. Because the leucine side chain structure 
more closely resembles that of phenylalanine than does isoleucine, the 
effect of a leucine substitution on ion channel kinetics would be 
predicted to be less than that of an isoleucine substitution. That this 
prediction does not always hold indicates that the structural 
requirements are more stringent, but the precise explanation for this is 
not clear at present given the high degree of similarity between the 
isomers (Fig. 10B). Additional studies will be required to resolve the 
precise nature of these requirements. 
Substitutions at GluN2A positions F636 and F637 also regulated 
ethanol sensitivity in an interactive manner: introduction of an alanine, 
cysteine, or tryptophan at either position altered the effect of 
substituting the same residue at the other position. Although there is 
no direct evidence that these positions form binding sites for ethanol, 
the ability of the positions to interactively and strongly regulate 
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ethanol sensitivity is consistent with this view and provides the best 
evidence for this to date (Ren et al., 2012 and Xu et al., 2015). 
Stronger evidence for this hypothesis awaits future studies 
demonstrating persistent alteration of NMDA receptor function by 
covalently-bound alcohol analogs or localization of ethanol or ethanol 
analogs to these positions using structural methods such as x-ray 
crystallography (Sauguet et al., 2013). As we observed for regulation 
of receptor gating, the effect of a single tryptophan substitution at 
either position could be reversed by substituting a second tryptophan 
at the other position. Unlike the opposing effects of tryptophan 
mutations at these positions on mean open time, however, ethanol 
sensitivity was markedly decreased in both the GluN2(F636W) and 
GluN2A(F637W) mutants, so that the restoration to normal ethanol 
sensitivity in the dual tryptophan mutant could not be explained by 
offsetting shifts in ethanol IC50 values. The effects of combining 
alanine and tryptophan substitutions on ethanol sensitivity were also 
unexpected: ethanol sensitivity was unchanged from the wild-type 
value in the F636W/F637W and F636W/F637A mutants, was decreased 
in the F636A/F637W mutant, but was increased in the dual alanine 
mutant. The underlying molecular events responsible for these 
observations are unclear at present, but may involve both a balancing 
of forces at this level of the alpha helix and an optimal molecular 
volume, with smaller side chain molecular volumes in a balanced helix 
(F636A/F637A, F636C/F637C) generally yielding higher ethanol 
sensitivities. The marked exception to this was the discrepancy 
observed between the leucine and isoleucine dual mutants: ethanol 
IC50 was unchanged in the F636L/F637L mutant, but was over two 
times greater in the F636I/F637I mutant. Although the magnitude of 
the difference in ethanol sensitivity between the mutants containing 
the isomeric amino acids leucine and isoleucine may be larger than 
expected, studies in both NMDA receptors and glycine receptors (Ye 
et al., 1998, Yamakura et al., 1999 and Ren et al., 2013) have 
reported similar differences in ethanol sensitivity or agonist potency 
between leucine and isoleucine mutants at various positions. Because 
leucine and isoleucine are identical in molecular volume and 
hydrophobicity, we interpret their disparate effects on ethanol 
sensitivity as evidence for specific structural requirements of the 
substituent side chains. 
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In summary, the results of the present paper demonstrate that 
the alcohol-sensitive positions F636 and F637 in the M3 domain of the 
GluN2A subunit interactively regulate ethanol inhibition and NMDA 
receptor function. This regulation appears to involve counteracting 
forces on the M3 helix at the level of these positions due to additional 
molecular interactions with nearby side chains. 
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